Itemoids

Novo

Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup

Quartz

qz.com › ozempic-23andme-novo-nordisk-1851680817

A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, the company that popularized consumer genetic testing, could soon be delisted from the Nasdaq. And Novo Nordisk is asking the U.S. Food and Drug Administration (FDA) to bar compounding pharmacies

Read more...